BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 508185)

  • 1. Optimal frequency of topical prednisolone administration.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1979 Nov; 97(11):2154-6. PubMed ID: 508185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorometholone acetate. A new ophthalmic derivative of fluorometholone.
    Kupferman A; Berrospi AR; Leibowitz HM
    Arch Ophthalmol; 1982 Apr; 100(4):640-1. PubMed ID: 7073584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
    Kupferman A; Leibowitz HM
    Invest Ophthalmol; 1975 Mar; 14(3):252-5. PubMed ID: 1116925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory medications.
    Leibowitz HM; Kupferman A
    Int Ophthalmol Clin; 1980; 20(3):117-34. PubMed ID: 6998894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel.
    Kupferman A; Ryan WJ; Leibowitz HM
    Arch Ophthalmol; 1981 Nov; 99(11):2028-9. PubMed ID: 7295153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of topically administered prednisolone acetate. Optimal concentration for treatment of inflammatory keratitis.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1976 Aug; 94(8):1387-9. PubMed ID: 949281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological equivalence of ophthalmic prednisolone acetate suspensions.
    Kupferman A; Leibowitz HM
    Am J Ophthalmol; 1976 Jul; 82(1):109-13. PubMed ID: 937444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged release hydrocortisone therapy.
    Lerman S; Davis P; Jackson WB
    Can J Ophthalmol; 1973 Jan; 8(1):114-8. PubMed ID: 4705522
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of concurrent topical corticosteroid and NSAID therapy of experimental keratitis.
    Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1226-9. PubMed ID: 3733368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effectiveness in the cornea of topically administered prednisolone.
    Leibowitz HM; Kupferman A
    Invest Ophthalmol; 1974 Oct; 13(10):757-63. PubMed ID: 4412044
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effectiveness of fluorometholone in inflammatory keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Oct; 93(10):1011-4. PubMed ID: 1180749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periocular injection of corticosteroids: an experimental evaluation of its role in the treatment of corneal inflammation.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1977 Feb; 95(2):311-4. PubMed ID: 836214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1980 Jul; 98(7):1287-90. PubMed ID: 7396786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of inflammation in the cornea and conjunctiva.
    Leibowitz HM
    Ophthalmology; 1980 Aug; 87(8):753-8. PubMed ID: 7443202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension.
    Johansen S; Rask-Pedersen E; Prause JU
    Acta Ophthalmol Scand; 1996 Jun; 74(3):253-8. PubMed ID: 8828722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oral and topical corticosteroid in rabbit corneas.
    Araki-Sasaki K; Katsuta O; Mano H; Nagano T; Nakamura M
    BMC Ophthalmol; 2016 Sep; 16(1):160. PubMed ID: 27596140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loading doses and extended dosing intervals in topical gentamicin therapy.
    Glasser DB; Gardner S; Ellis JG; Pettit TH
    Am J Ophthalmol; 1985 Mar; 99(3):329-32. PubMed ID: 3976808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and corneal anti-inflammatory effect of topical suprofen.
    Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):628-31. PubMed ID: 3957583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
    Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
    Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential.
    Leibowitz HM; Ryan WJ; Kupferman A
    Arch Ophthalmol; 1992 Jan; 110(1):118-20. PubMed ID: 1731703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.